🔗 Share this article

A shadow economy for unapproved weight-loss drugs is being driven by social media fitness personalities and vendors on messaging platforms, based on recent findings.

Investigational Treatment Acquiring Popularity Via Social Media

The experimental drug, which is still in clinical trials, is being promoted by online personalities for its alleged weight-reducing properties. Followers are encouraged to contact these accounts directly for supplier links, while also receiving promotional offers.

Thriving Trade on Messaging Platforms

Additionally, a robust market exists on messaging services, where communities with numerous of members share “before and after” images, administration instructions and claims of rapid British shipping. Vendors promote the substance there before directing buyers to other platforms for purchases.

Understanding Retatrutide

Retatrutide is an investigational injection developed by US drugmaker Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Early trials suggest it could help individuals lose up to 25% of their body weight. Nicknamed the “triple G”, the drug is being promoted online as the successor to Ozempic.

Medical Experts Express Worries

However, physicians and pharmacists have cautions that the distribution of what remains an unapproved drug in the United Kingdom is worrisome and could lead to individuals injecting substances of unknown origin.

Several experts stated the popularity for retatrutide could be connected to the rising cost of licensed slimming treatments such as Mounjaro.

Regulatory Position and Implementation

Selling the unapproved drug on TikTok or Telegram is prohibited in the UK, as it is an unapproved drug that must not be promoted or distributed for human use under the British medical regulations.

Several content creators attempt to circumvent the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and distribution can still breach medicines, advertising, and consumer laws, risking fines, prosecution or imprisonment.

Platform Reaction and Material Elimination

Based on TikTok, the platform has taken down problematic content and prohibited related keywords and query recommendations. The company stated it was dedicated to keeping the platform safe and investing in strengthening compliance measures.

Digital Trading Activities

Investigations also found groups with up to 9,000 members marketing the experimental drug using the platform's integrated discovery tool, which functions like a public directory. Entering “retatrutide” immediately brings up groups with thousands of users, filled with images of weight loss, glowing reviews and step-by-step instructions for mixing or injecting at home.

Within minutes of entering one group, a vendor posted contact information, where the majority of purchases take place. The seller sent an instruction manual and guaranteed delivery within two days. When questioned whether the substance was genuine, one vendor responded: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. None asked about body mass, medical conditions or previous experience.

Item Information and Costs

Within these communities, posts show black plastic parcels with postal service labels, stating to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at home with purified liquid, or ready-to-use injectors usually sold at 160 pounds for 20mg. When asked how long a injector should last, sellers give contradictory responses ranging from a several days to “depends on your body”.

Service Oversight and Security Actions

A spokesperson for the messaging service stated it regularly monitored harmful content on its service including material that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are administering materials they can’t verify. Although the science behind this drug is valid, these digital products may not include what they advertise,” stated a pharmacy expert, the director of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in interest to recent price rises for approved weight-loss medications such as Mounjaro. “With prices increasing, individuals are using online platforms. But counterfeit injections are extremely dangerous. You cannot know what’s contained or whether the environment they were produced in was sterile,” she explained.

Her team has previously seen patients injured by self-injection from unconfirmed sources. “We understand the disappointment, but buying from messaging apps or WhatsApp is taking chances with your health,” said Wyllie. “These materials could be impure or incorrectly dosed.”

Producer Statement

A spokesperson from Eli Lilly stated the substance was in third stage clinical trials and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Consequently at this time no one can sell [it] for human use,” they said, noting that any item “misleadingly claiming itself as a Lilly experimental substance not yet approved … may expose users to possibly serious health risks”.